KR100295026B1 - 피라졸로(4,3-c)피리딘,이의제조방법및이를포함하는약제학적조성물 - Google Patents

피라졸로(4,3-c)피리딘,이의제조방법및이를포함하는약제학적조성물 Download PDF

Info

Publication number
KR100295026B1
KR100295026B1 KR1019930022006A KR930022006A KR100295026B1 KR 100295026 B1 KR100295026 B1 KR 100295026B1 KR 1019930022006 A KR1019930022006 A KR 1019930022006A KR 930022006 A KR930022006 A KR 930022006A KR 100295026 B1 KR100295026 B1 KR 100295026B1
Authority
KR
South Korea
Prior art keywords
compound
formula
pyrazolo
pyridine
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930022006A
Other languages
English (en)
Korean (ko)
Other versions
KR940009185A (ko
Inventor
셔츠케 그레고리엠
케빈제이.카플스
죤디.토머4세
Original Assignee
훽스트-러셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 훽스트-러셀 파마슈티칼즈 인코포레이티드 filed Critical 훽스트-러셀 파마슈티칼즈 인코포레이티드
Publication of KR940009185A publication Critical patent/KR940009185A/ko
Application granted granted Critical
Publication of KR100295026B1 publication Critical patent/KR100295026B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
KR1019930022006A 1992-10-22 1993-10-22 피라졸로(4,3-c)피리딘,이의제조방법및이를포함하는약제학적조성물 Expired - Fee Related KR100295026B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/964,690 US5264576A (en) 1992-10-22 1992-10-22 Pyrazolo[4,3-c]pyridines which are intermediates
US07/964,690 1992-10-22

Publications (2)

Publication Number Publication Date
KR940009185A KR940009185A (ko) 1994-05-20
KR100295026B1 true KR100295026B1 (ko) 2001-09-17

Family

ID=25508857

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930022006A Expired - Fee Related KR100295026B1 (ko) 1992-10-22 1993-10-22 피라졸로(4,3-c)피리딘,이의제조방법및이를포함하는약제학적조성물

Country Status (18)

Country Link
US (4) US5264576A (enExample)
EP (1) EP0594001B1 (enExample)
JP (1) JP2656211B2 (enExample)
KR (1) KR100295026B1 (enExample)
CN (1) CN1049658C (enExample)
AT (1) ATE195522T1 (enExample)
AU (1) AU671305B2 (enExample)
CA (1) CA2108941A1 (enExample)
DE (1) DE69329231T2 (enExample)
DK (1) DK0594001T3 (enExample)
ES (1) ES2152237T3 (enExample)
FI (1) FI103890B (enExample)
GR (1) GR3034819T3 (enExample)
MX (1) MX9306552A (enExample)
NO (1) NO300374B1 (enExample)
NZ (1) NZ250003A (enExample)
PT (1) PT594001E (enExample)
TW (1) TW252114B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300498A (en) * 1993-06-04 1994-04-05 Hoechst-Roussel Pharmaceuticals Incorporated 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, esters, amides and related compounds
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
US5565413A (en) * 1994-12-06 1996-10-15 Zeneca Limited Substituted pyridyl phenyl ketone herbicides
US7589202B2 (en) 2000-08-14 2009-09-15 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
US20070117785A1 (en) * 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
EP1309593B1 (en) 2000-08-14 2006-03-15 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
US20050101587A9 (en) * 2000-08-14 2005-05-12 Butler Christopher R. Method for treating allergies using substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
HK1052705B (en) 2000-08-14 2006-09-29 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazole
CN1642973A (zh) 2000-09-06 2005-07-20 奥索-麦克尼尔药品公司 治疗变态反应的方法
CN1656079A (zh) * 2002-05-31 2005-08-17 卫材株式会社 吡唑化合物和含有该化合物的药物组合物
US8633318B2 (en) * 2008-09-16 2014-01-21 Proximagen Ltd Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorder
CN102558174B (zh) * 2011-08-23 2014-03-19 天津市斯芬克司药物研发有限公司 一种全新吡唑并[4,3-c]吡啶化合物的发明及其合成方法
KR20150028999A (ko) 2012-06-27 2015-03-17 에프. 호프만-라 로슈 아게 5-아자인다졸 화합물 및 이의 사용 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994890A (en) * 1974-01-31 1976-11-30 Chugai Seiyaku Kabushiki Kaisha 1-Aminoalkyl, 3-phenyl indazoles
JPS5944314B2 (ja) * 1975-01-15 1984-10-29 中外製薬株式会社 インダゾ−ル誘導体の製法
JPS5936627B2 (ja) * 1975-07-25 1984-09-05 中外製薬株式会社 インダゾ−ル誘導体の製法
DK27383A (da) * 1982-02-17 1983-08-18 Lepetit Spa Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
JPH0615542B2 (ja) * 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
EP0338087A4 (en) * 1987-10-13 1991-07-24 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrazole compounds, process for their preparation, and their medicinal use
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
EP0494774A1 (en) * 1991-01-11 1992-07-15 MERCK SHARP & DOHME LTD. Indazole-substituted fivemembered heteroaromatic compounds
GB9216783D0 (en) * 1992-08-07 1992-09-23 Ici Plc Heterocyclic derivatives
US5300478A (en) * 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds

Also Published As

Publication number Publication date
EP0594001A1 (en) 1994-04-27
DK0594001T3 (da) 2000-10-30
MX9306552A (es) 1994-06-30
PT594001E (pt) 2001-01-31
NO933784D0 (no) 1993-10-21
FI934621L (fi) 1994-04-23
CN1049658C (zh) 2000-02-23
FI934621A0 (fi) 1993-10-20
DE69329231D1 (de) 2000-09-21
EP0594001B1 (en) 2000-08-16
ES2152237T3 (es) 2001-02-01
NZ250003A (en) 1996-03-26
NO300374B1 (no) 1997-05-20
US5264576A (en) 1993-11-23
CN1099033A (zh) 1995-02-22
GR3034819T3 (en) 2001-02-28
US5428169A (en) 1995-06-27
FI103890B1 (fi) 1999-10-15
ATE195522T1 (de) 2000-09-15
FI103890B (fi) 1999-10-15
KR940009185A (ko) 1994-05-20
US5380847A (en) 1995-01-10
DE69329231T2 (de) 2001-03-29
TW252114B (enExample) 1995-07-21
CA2108941A1 (en) 1994-04-23
NO933784L (no) 1994-04-25
JPH06192257A (ja) 1994-07-12
AU671305B2 (en) 1996-08-22
AU4912893A (en) 1994-05-05
JP2656211B2 (ja) 1997-09-24
US5296491A (en) 1994-03-22

Similar Documents

Publication Publication Date Title
EP3209651B9 (en) Carbazole derivatives
US6333336B1 (en) Pyrazolo-pyridine derivatives as ligands for GABA receptors
TW201102385A (en) Substituted triazolopyridines and analogs thereof
JP2656211B2 (ja) ピラゾロ〔４，３−ｃ〕ピリジン類、その製造方法およびそれを含有するセロトニン再摂取阻害剤
JPH07179466A (ja) イミダゾール−４−イルピペリジン誘導体、それらの製法と医薬への応用
BR112021013429A2 (pt) Composto, composição farmacêutica, e, uso do composto
JP4290555B2 (ja) 環縮合したピラゾール誘導体
CZ75496A3 (en) Piperidine derivatives, process of their preparation, said derivatives as medicaments and pharmaceutical composition containing such derivatives
JP2004010619A (ja) セレトニンレセプターに対するリガンドとしての２，７−置換オクタヒドロ−１ｈ−ピリド［１，２−ａ］ピラジン誘導体
US5912246A (en) Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases
EP0703232B1 (en) 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors
KR100309215B1 (ko) 항정신병제로서의피리딘이미닐-1,2-벤즈이속사졸및-벤즈이소티아졸
US6013654A (en) Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
CN101605790A (zh) 新的氨基吡咯并[1,2-a]吲哚和氨基哒嗪并[1,6-a]吲哚衍生物、它们的制备方法以及包含它们的药物组合物
EP0406719A1 (en) 4h-indolo(1,2-d)(1,2,4)triazolo (4,3-a)(1,4)benzodiazepines, a process for their preparation and their use as medicaments
PL168320B1 (pl) S p osób wytwarzania nowych pochodnych tetrahydroimidazo[1,4]benzodiazepin-2-(ti)onu PL PL PL
JP2007523109A (ja) 複素環式Ｇａｂａ−Ａサブタイプ選択的レセプターモジュレーター
JPH06345764A (ja) ６−ピペラジニル−１Ｈ−ピラゾロ〔３，４−ｂ〕ピリジン−３−カルボン酸、エステル、アミドおよび関連化合物、それらの製法、ならびに医薬としてのそれらの使用
JPH0227357B2 (enExample)
JPH0649067A (ja) ４，５−ジヒドロピラゾロ〔３，４−ａ〕アクリジン類、それらの製造方法および医薬としてのそれらの使用
HK1238642B (en) Carbazole derivatives
HK1238642A1 (en) Carbazole derivatives

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040425

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040425

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000